News

The successful launch of the cruise business not only drives profit growth but also introduces new customers to TDR. Stronger co-operation with online travel agencies leads to a higher percentage of ...
License agreement supports Madrigal's pipeline strategy to develop innovative combination treatments for MASH, anchored by its foundational therapy Rezdiffra (resmetirom) Combining Rezdiffra with the ...
EVERTEC, Inc. (NYSE: EVTC) ("Evertec" or the "Company") today announced results for the second quarter ended June 30, 2025.
Net loss for the second quarter of 2025 was $ (3.8) million, an improvement of $5.7 million versus a net loss of $ (9.6) million in the second quarter of 2024. Net loss margin for the second quarter ...
Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) ('Arqit”), a global leader in quantum‑safe encryption, today announced the launch of ...
Approval of the Merger requires the affirmative vote of holders of a majority of all of the outstanding shares of Heliogen's common stock as of the record date, June 30, 2025. Stockholders are ...
Microsoft Corp. is in advanced talks to land a deal that could give it ongoing access to critical OpenAI technology, an ...
Vertiv Holdings Co (NYSE: VRT), a global leader in critical digital infrastructure, today reported financial results for its ...
Asia’s air freight demand surges as 50% US tariffs loom, triggering rate hikes, capacity crunch, and pre-deadline export rush ...
Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.
Negotiations over OpenAI’s future as a profit-company have dragged on for months. Microsoft, which backed OpenAI with some ...